beijing tongrentang channel research: the high-end series has started to layout, there are still "gaps" in the out-of-hospital channels, and mergers and acquisitions have taken root in the in-hospital market | company research

① This Friday, the chairman of beijing tongrentang, Di Shubing, officially assumes the role of general manager of beijing tongrentang Group. ② The high-end imperial medicine series is primarily sold in beijing tongrentang pharmacies and remains hard to find in some city chain pharmacies. The company stated that the overall sales situation is in line with expectations. ③ beijing tongrentang Commercial Company acquired 51% of Honghui Medical for 0.105 billion, exploring the medical market, but there are still gaps in the outpatient medium and large chain market.

cls.cnNov 30 22:42

Tasly Pharmaceutical Group: Some products price reduction led to a decline in Q3 gross margin. All parties are actively promoting the trade with China Resources Sanjiu Medical & Pharmaceutical | Focus on earnings conference

① Affected by the overall low prosperity of the pharmacy industry, the company's pharmaceutical commerce sector saw a decline in revenue in the third quarter this year; the pharmaceutical industry sector's revenue grew year-on-year, but price reductions on some products led to a decrease in gross margin, and the company expects the gross margin to remain stable in the future. ② Regarding the equity trade matters between the company's major shareholder and china resources sanjiu medical & pharmaceutical, the company's general manager Cai Jinyong stated that the company and relevant parties are actively promoting various works for this transaction.

cls.cnNov 27 22:29

Rare opportunity for precise "top escaping"? After ten years, hongda high-tech holding reduces shareholding in haining china leather market | Quick announcement reading.

① Hongda high-tech holding sold 11.15 million shares of Haining China Leather Market, with a transaction amount of 71.65 million yuan. ② The company holds a total of 30.3 million shares of Haining China Leather Market, which were acquired before the initial public offering, with the lockup period lifted and listed for circulation in 2014, and it has been ten years since then. ③ There has been unusual stock price movement in Haining China Leather Market over the past ten days, with five consecutive limit ups from November 15 to November 21, followed by a rapid decline from November 25 to 27, with today's closing price at 4.88 yuan.

cls.cnNov 27 22:11

After a 10-year wait! hongda high-tech holding "seizes market opportunities" to reduce shareholding in haining china leather market.

1. Hongda high-tech holding announced that it recently sold part of its stocks in haining china leather market for a total amount of 71.6589 million yuan, accounting for 0.87% of haining china leather market's total equity. 2. After the shareholding, hongda high-tech holding still holds 19.15 million shares of haining china leather market, accounting for 1.49% of the total equity.

cls.cnNov 27 20:56

Is Guangxi Wuzhou Zhongheng Group planning to sell the controlling stake of Chongqing Lummy Pharmaceutical after years of consecutive losses? | Quick read announcement

①Guangxi Wuzhou Zhongheng Group intends to transfer the shares held directly in Chongqing Lummy Pharmaceutical through public solicitation, and the controlling shareholder and actual controller of the latter may change. ②The story of Guangxi Wuzhou Zhongheng Group's investment in Chongqing Lummy Pharmaceutical began in November 2019 and became a major shareholder of Chongqing Lummy Pharmaceutical in April of the following year, making Guangxi State-owned Assets Supervision and Administration Commission the actual controller of Chongqing Lummy Pharmaceutical since then. ③In recent years, Chongqing Lummy Pharmaceutical has been in a continuous loss-making state.

cls.cnNov 26 22:55

TJ Darentang USD: Wang Lei replaces Zhang Mingrui as the chairman, the company's development global strategy "will not change" | Speed ​​reading announcement

① Zhang Mingrui applied to resign as the chairman, director, and chairman of the global strategy committee of tj darentang usd due to work changes. ② Wang Lei, the general manager, took over as chairman, with company officials stating that the enterprise development strategy "will not change".

cls.cnNov 26 21:20